Loading...

Michael Peters, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address513 Parnassus Ave
San Francisco CA 94143
Phone415-443-9255
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Emory UniversityBA2002Economics
    State University of New York, Stony BrookMD2007Medicine
    University of ColoradoInternal Medicine2010Medicine
    University of California, San FranciscoPulmonary/Critical Care2014Medicine
    University of California, San FranciscoMAS2015Epidemiology

    Collapse Overview 
    Collapse Overview
    Dr. Peters is an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine and the Department of Medicine at UCSF.

    Many asthma patients respond well to traditional asthma medications including inhaled corticosteroids. However, a significant subgroup of asthmatics (many of whom are older and obese) has severe disease that causes frequent exacerbations and significant disability. Dr. Peters research program focuses on understanding why some patients develop steroid resistant asthma in order to improve treatment options for these patients.

    Clinically, Dr. Peters works in the UCSF Severe Asthma Clinic and he is an attending in the UCSF Critical Care Units.


    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Peters M, Nguyen ML, Dunican EM. Biomarkers of Airway Type-2 Inflammation and Integrating Complex Phenotypes to Endotypes in Asthma. Curr Allergy Asthma Rep. 2016 Oct; 16(10):71. PMID: 27613654.
      View in: PubMed
    2. Gordon ED, Palandra J, Wesolowska-Andersen A, Ringel L, Rios CL, Lachowicz-Scroggins ME, Sharp LZ, Everman JL, MacLeod HJ, Lee JW, Mason RJ, Matthay MA, Sheldon RT, Peters M, Nocka KH, Fahy JV, Seibold MA. IL1RL1 asthma risk variants regulate airway type 2 inflammation. JCI Insight. 2016 Sep 8; 1(14):e87871. PMID: 27699235.
      View in: PubMed
    3. Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, Bacharier LB, Bleecker ER, Comhair SA, Coverstone A, DeBoer M, Erzurum SC, Fain SB, Fajt M, Fitzpatrick AM, Gaffin J, Gaston B, Hastie AT, Hawkins GA, Holguin F, Irani AM, Israel E, Levy BD, Ly N, Meyers DA, Moore WC, Myers R, Opina MT, Peters M, Schiebler ML, Sorkness RL, Teague WG, Wenzel SE, Woodruff PG, Mauger DT, Fahy JV, Jarjour NN, et al. Inflammatory and Co-Morbid Features of Patients with Severe Asthma and Frequent Exacerbations. Am J Respir Crit Care Med. 2016 Aug 24. PMID: 27556234.
      View in: PubMed
    4. Peters M, Fahy JV. Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma. Eur Respir J. 2016 Aug; 48(2):291-3. PMID: 27478182.
      View in: PubMed
    5. Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz-Scroggins ME, Peters M, Wesolowska-Andersen A, Gonzalez JR, MacLeod HJ, Christian LS, Yuan S, Barry L, Woodruff PG, Ansel KM, Nocka K, Seibold MA, Fahy JV, et al. Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proc Natl Acad Sci U S A. 2016 Jul 18. PMID: 27432971.
      View in: PubMed
    6. Peters M, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Holguin F, Wenzel SE, Woodruff PG, Bleecker ER, Fahy JV, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016 Jul; 4(7):574-84. PMID: 27283230.
      View in: PubMed
    7. Kerr SC, Carrington SD, Oscarson S, Gallagher ME, Solon M, Yuan S, Ahn JN, Dougherty RH, Finkbeiner WE, Peters M, Fahy JV. Intelectin-1 is a prominent protein constituent of pathologic mucus associated with eosinophilic airway inflammation in asthma. Am J Respir Crit Care Med. 2014 Apr 15; 189(8):1005-7. PMID: 24735037; PMCID: PMC4098098.
      View in: PubMed, PubMed Central
    8. Peters M, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014 Feb; 133(2):388-94. PMID: 24075231; PMCID: PMC3981552.
      View in: PubMed, PubMed Central
    9. Peters M, Fahy JV. Type 2 immune responses in obese individuals with asthma. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):633-4. PMID: 24032378.
      View in: PubMed
    10. Szema AM, Peters M, Weissinger KM, Gagliano CA, Chen JJ. New-onset asthma among soldiers serving in Iraq and Afghanistan. Allergy Asthma Proc. 2010 Sep-Oct; 31(5):67-71. PMID: 20929596.
      View in: PubMed
    11. Miller JD, Peters M, Oran AE, Beresford GW, Harrington L, Boss JM, Altman JD. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells. J Immunol. 2002 Jul 15; 169(2):693-701. PMID: 12097371.
      View in: PubMed
    Michael's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (67) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (10) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP